NCT05520827View on ClinicalTrials.gov

A Study in Healthy Men to Test How Different Doses of BI 1584862 Are Tolerated and How BI 1584862 is Taken up in the Body With or Without Food

PHASE1CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

September 29, 2022

Primary Completion Date

March 6, 2023

Study Completion Date

March 6, 2023

Conditions
Healthy
Interventions
DRUG

BI 1584862

BI 1584862

DRUG

Placebo

Placebo

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY